| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Departments of Biochemistry*
and
Medicine,
University of Washington,
Seattle, Washington
The matricellular angiogenesis inhibitor, thrombospondin (TSP) 2, has been shown to be an important modulator of wound healing and the foreign body response. Specifically, TSP2-null mice display improved healing with minimal scarring and form well-vascularized foreign body capsules. In this study we performed subcutaneous implantation of sponges and investigated the resulting angiogenic and fibrogenic responses. Histological and immunohistochemical analysis of sponges, excised at 7, 14, and 21 days after implantation, revealed significant differences between TSP2-null and wild-type mice. Most notably, TSP2-null mice exhibited increased angiogenesis and fibrotic encapsulation of the sponge. However, invasion of dense tissue was compromised, even though its overall density was increased. Furthermore, histomorphometry and biochemical assays demonstrated a significant increase in the extracellular distribution of matrix metalloproteinase (MMP) 2, but no change in the levels of active transforming growth factor-ß1. The alterations in neovascularization, dense tissue invasion, and MMP2 in TSP2-null mice coincided with the deposition of TSP2 in the extracellular matrix of wild-type animals. These observations support the proposed role of TSP2 as a modulator of angiogenesis and matrix remodeling during tissue repair. In addition, they provide in vivo evidence for a newly proposed function of TSP2 as a modulator of extracellular MMP2 levels.
This article has been cited by other articles:
![]() |
S. MacLauchlan, E. A. Skokos, A. Agah, J. Zeng, W. Tian, J. M. Davidson, P. Bornstein, and T. R. Kyriakides Enhanced Angiogenesis and Reduced Contraction in Thrombospondin-2-null Wounds Is Associated With Increased Levels of Matrix Metalloproteinases-2 and -9, and Soluble VEGF J. Histochem. Cytochem., April 1, 2009; 57(4): 301 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacLauchlan, E. A. Skokos, N. Meznarich, D. H. Zhu, S. Raoof, J. M. Shipley, R. M. Senior, P. Bornstein, and T. R. Kyriakides Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9 J. Leukoc. Biol., April 1, 2009; 85(4): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Krady, J. Zeng, J. Yu, S. MacLauchlan, E. A. Skokos, W. Tian, P. Bornstein, W. C. Sessa, and T. R. Kyriakides Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis Am. J. Pathol., September 1, 2008; 173(3): 879 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koch, P. Hoppmann, A. de Waha, A. Schomig, and A. Kastrati Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence Hum. Mol. Genet., April 15, 2008; 17(8): 1120 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Behera, L. Feng, B. Yonish, W. Catherino, S.-H. Jung, and P. C. Leppert Thrombospondin-1 and Thrombospondin-2 mRNA and TSP-1 and TSP-2 Protein Expression in Uterine Fibroids and Correlation to the Genes COL1A1 and COL3A1 and to the Collagen Cross-link Hydroxyproline Reproductive Sciences, December 1, 2007; 14(8_suppl): 63 - 76. [Abstract] [PDF] |
||||
![]() |
O. I. Stenina, E. J. Topol, and E. F. Plow Thrombospondins, Their Polymorphisms, and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1886 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Daniel, K. Amann, B. Hohenstein, P. Bornstein, and C. Hugo Thrombospondin 2 Functions as an Endogenous Regulator of Angiogenesis and Inflammation in Experimental Glomerulonephritis in Mice J. Am. Soc. Nephrol., March 1, 2007; 18(3): 788 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marsolais, E. Duchesne, C. H. Cote, and J. Frenette Inflammatory cells do not decrease the ultimate tensile strength of intact tendons in vivo and in vitro: protective role of mechanical loading J Appl Physiol, January 1, 2007; 102(1): 11 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Fears, J. R. Grammer, J. E. Stewart Jr., D. S. Annis, D. F. Mosher, P. Bornstein, and C. L. Gladson Low-Density Lipoprotein Receptor-Related Protein Contributes to the Antiangiogenic Activity of Thrombospondin-2 in a Murine Glioma Model Cancer Res., October 15, 2005; 65(20): 9338 - 9346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lefebvre-Lavoie, J. G. Lussier, and C. L. Theoret Profiling of differentially expressed genes in wound margin biopsies of horses using suppression subtractive hybridization Physiol Genomics, July 14, 2005; 22(2): 157 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agah, T. R. Kyriakides, and P. Bornstein Proteolysis of Cell-Surface Tissue Transglutaminase by Matrix Metalloproteinase-2 Contributes to the Adhesive Defect and Matrix Abnormalities in Thrombospondin-2-Null Fibroblasts and Mice Am. J. Pathol., July 1, 2005; 167(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Puolakkainen, A. D. Bradshaw, R. A. Brekken, M. J. Reed, T. Kyriakides, S. E. Funk, M. D. Gooden, R. B. Vernon, T. N. Wight, P. Bornstein, et al. SPARC-thrombospondin-2-double-null Mice Exhibit Enhanced Cutaneous Wound Healing and Increased Fibrovascular Invasion of Subcutaneous Polyvinyl Alcohol Sponges J. Histochem. Cytochem., May 1, 2005; 53(5): 571 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. W. Park, Y. M. Kang, J. Butterfield, M. Detmar, J. J. Goronzy, and C. M. Weyand Thrombospondin 2 Functions as an Endogenous Regulator of Angiogenesis and Inflammation in Rheumatoid Arthritis Am. J. Pathol., December 1, 2004; 165(6): 2087 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Kyriakides, M. J. Foster, G. E. Keeney, A. Tsai, C. M. Giachelli, I. Clark-Lewis, B. J. Rollins, and P. Bornstein The CC Chemokine Ligand, CCL2/MCP1, Participates in Macrophage Fusion and Foreign Body Giant Cell Formation Am. J. Pathol., December 1, 2004; 165(6): 2157 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale Cell-Matrix Signaling and Thrombospondin: Another Link to Myocardial Matrix Remodeling Circ. Res., September 3, 2004; 95(5): 446 - 448. [Full Text] [PDF] |
||||
![]() |
K. O. Yee, M. Streit, T. Hawighorst, M. Detmar, and J. Lawler Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-{beta} Am. J. Pathol., August 1, 2004; 165(2): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kokenyesi, L. C. Armstrong, A. Agah, R. Artal, and P. Bornstein Thrombospondin 2 Deficiency in Pregnant Mice Results in Premature Softening of the Uterine Cervix Biol Reprod, February 1, 2004; 70(2): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sadoun and M. J. Reed Impaired Angiogenesis in Aging Is Associated with Alterations in Vessel Density, Matrix Composition, Inflammatory Response, and Growth Factor Expression J. Histochem. Cytochem., September 1, 2003; 51(9): 1119 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koike, R. B. Vernon, M. D. Gooden, E. Sadoun, and M. J. Reed Inhibited Angiogenesis in Aging: A Role for TIMP-2 J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2003; 58(9): B798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Kyriakides, P. Rojnuckarin, M. A. Reidy, K. D. Hankenson, T. Papayannopoulou, K. Kaushansky, and P. Bornstein Megakaryocytes require thrombospondin-2 for normal platelet formation and function Blood, May 15, 2003; 101(10): 3915 - 3923. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agah, T. R. Kyriakides, J. Lawler, and P. Bornstein The Lack of Thrombospondin-1 (TSP1) Dictates the Course of Wound Healing in Double-TSP1/TSP2-Null Mice Am. J. Pathol., September 1, 2002; 161(3): 831 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Armstrong, B. Bjorkblom, K. D. Hankenson, A. W. Siadak, C. E. Stiles, and P. Bornstein Thrombospondin 2 Inhibits Microvascular Endothelial Cell Proliferation by a Caspase-independent Mechanism Mol. Biol. Cell, June 1, 2002; 13(6): 1893 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Streit, A. E. Stephen, T. Hawighorst, K. Matsuda, B. Lange-Asschenfeldt, L. F. Brown, J. P. Vacanti, and M. Detmar Systemic Inhibition of Tumor Growth and Angiogenesis by Thrombospondin-2 Using Cell-based Antiangiogenic Gene Therapy Cancer Res., April 1, 2002; 62(7): 2004 - 2012. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |